R2033054 |
Lazertinib |
Lazertinib is a potent, highly mutant-selective, blood-brain barrier permeable,
|
R2033055 |
Mapracorat |
Mapracorat is a novel non-steroidal selective glucocorticoid receptor agonist.
|
R2033056 |
MAZ51 |
MAZ51 is a selective inhibitor of VEGFR-3 (Flt-4) tyrosine kinase.MAZ51 inhibits
|
R2033057 |
MBX8025 |
Seladelpar (MBX-8025) is an orally active, potent (50% effect concentration EC50
|
R2033058 |
MK7246 |
MK-7246 is a potent and selective CRTH2 antagonist with a Ki of 2.5±0.5 nM.
|
R2033059 |
NKP-1339 |
NKP-1339 (IT-139) is the first-in-class ruthenium-based anticancer agent in deve
|
R2033060 |
PD-1-IN-1 |
PD-1-IN-1 is an inhibitor of programmed cell dealth-1 (PD-1) extracted from pate
|
R2033061 |
Pemafibrate |
Pemafibrate is a highly selective PPARα agonist, with an EC50 of 1 nM.
|
R2033062 |
Pradefovir mesylate |
Pradefovir mesylate is a good substrate for liver CYP3A4.Pradefovir is converted
|
R2033063 |
Rimegepant;BMS-927711 |
Rimegepant (BMS-927711) is a highly potent, oral calcitonin gene-related peptide
|
R2033064 |
SKL2001 |
SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity.SK
|
R2033065 |
STF083010 |
STF-083010 is a specific IRE1α inhibitor.STF-083010 inhibits Ire1 endonuclease a
|
R2033066 |
TAK779 |
TAK-779 is a potent and selective nonpeptide antagonist of CCR5 and CXCR3, with
|
R2033067 |
TFAP |
TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor, with an IC50 of 0.8 μM.
|
R2033068 |
Triapine |
3-AP (PAN-811) is a novel inhibitor of the M2 subunit of ribonucleotide reductas
|
R2033069 |
TRx0237 |
Leucomethylene blue (Mesylate) is a common reduced form of Methylene Blue, Methy
|
R2033070 |
UK5099;UK-5099(PF-1005023) |
UK-5099 (PF-1005023) is a potent inhibitor of the mitochondrial pyruvate carrier
|
R2033071 |
Z360;Nastorazepide(Z-360) |
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-deriv
|
R2033072 |
ABBV-744 |
ABBV-744 is a highly BDII-selective BET bromodomain inhibitor, used in the resea
|
R2033073 |
Alofanib(RPT835) |
Alofanib (RPT835) is a potent and selective allosteric inhibitor of fibroblast g
|
R2033074 |
BI-409306 |
BI-409306 is a potent and selective PDE9A inhibitor, with an IC50 of 52 nM, and
|
R2033075 |
B-Raf inhibitor 1 dihydrochloride |
B-Raf inhibitor 1 is a potent Raf kinase inhibitor with Kis of 1 nM, 1 nM, and 0
|
R2033076 |
BV6 |
BV6 is an antagonist of cIAP1 and XIAP, members of the inhibitors of apoptosis (
|
R2033077 |
GSK2807 Trifluoroacetate |
GSK2807 Trifluoroacetate is a potent, selective and SAM-competitive inhibitor of
|
R2033078 |
LY2828360 |
LY2828360 is a slowly acting but efficacious G protein-biased cannabinoid (CB2)
|